Kevin Alan Schulman

Adjunct Professor in the Department of Medicine
Director, Center for Clinical and Genetic Economics
Research Professor of Global Health
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Email address kevin.schulman@duke.edu

Kevin A. Schulman, MD, MBA, is a professor of medicine and the Gregory Mario and Jeremy Mario Professor of Business Administration (2010 - 2016) at Duke University. He is a visiting professor of business administration at Harvard Business School. He holds several leadership appointments at Duke. He is an associate director of the Duke Clinical Research Institute in the School of Medicine, the country's largest academic clinical research organization. In Duke's Fuqua School of Business, he served for more than a decade as the director of the Health Sector Management program, the Master of Management in Clinical Informatics degree program, and the Center for the Study of Health Management. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Medicine Institute; and the Duke Global Health Institute.

Dr. Schulman is a distinguished researcher who has received more than $48 million in research grants. His research interests include health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; health economics and economic evaluation in clinical research; and medical decision making, especially in patients with life-threatening conditions. He teaches courses in biotechnology, health policy, and health IT strategy.

Dr. Schulman has published nearly 400 articles and book chapters; his peer-reviewed papers have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is the senior associate editor of Health Services Research and a member of the editorial/advisory boards of the American Journal of Medicine and the American Heart Journal.

A recipient of numerous awards, Dr. Schulman is a fellow of the American College of Physicians and an elected member of the American Society for Clinical Investigation. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. He has served as session chair and panelist at dozens of medical and health care conferences. Dr. Schulman has also served on numerous grant review committees for the National Institutes of Health, the Robert Wood Johnson Foundation, and other bodies. He is a member of the advisory board for the Centre for Healthcare Policy and Management at the China Europe International Business School. In 2010-2011, he was a mentor for the Commonwealth Fund's Harkness Fellowships in Health Care Policy and Practice. He is the founding president of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.

Dr. Schulman received his MD from the New York University School of Medicine and his MBA, with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board-certified in internal medicine.

Publications

Jimoh, L, Pate, MA, Lin, L, and Schulman, KA. "A model for the adoption of ICT by health workers in Africa." Int J Med Inform 81, no. 11 (November 2012): 773-781.

PMID
22986218
Full Text

Valverde, AM, Reed, SD, and Schulman, KA. "Proposed 'grant-and-access' program with price caps could stimulate development of drugs for very rare diseases." Health Aff (Millwood) 31, no. 11 (November 2012): 2528-2535. (Review)

PMID
23129684
Full Text

Reed, SD, Li, Y, Dunlap, ME, Kraus, WE, Samsa, GP, Schulman, KA, Zile, MR, and Whellan, DJ. "In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial)." Am J Cardiol 110, no. 8 (October 15, 2012): 1150-1155.

PMID
22762718
Full Text

Reed, SD, Li, Y, Ellis, SJ, Isitt, JJ, Cheng, S, Schulman, KA, and Whellan, DJ. "Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION." J Card Fail 18, no. 10 (October 2012): 784-791.

PMID
23040114
Full Text

Gellad, ZF, Muir, AJ, McHutchison, JG, Sievert, W, Sharara, AI, Brown, KA, Flisiak, R, Jacobson, IM, Kershenobich, D, Manns, MP, Schulman, KA, and Reed, SD. "Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response." Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research 15, no. 6 (September 2012): 876-886.

PMID
22999138
Full Text

Richman, BD, Hall, MA, and Schulman, KA. "Overbilling and informed financial consent--a contractual solution." N Engl J Med 367, no. 5 (August 2, 2012): 396-397.

PMID
22853013
Full Text

Dinan, MA, Curtis, LH, Carpenter, WR, Biddle, AK, Abernethy, AP, Patz, EF, Schulman, KA, and Weinberger, M. "Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 30, no. 22 (August 2012): 2725-2730.

PMID
22753917
Full Text

Li, Y, Neilson, M, Whellan, DJ, Schulman, KA, Levy, WC, and Reed, SD. "Seattle Heart Failure Model Scores are Significantly Predictive of Health Utilities and Their Change Over Time." August 2012.

Full Text

Kamble, S, Schulman, KA, and Reed, SD. "Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States." Value Health 15, no. 5 (July 2012): 632-638.

PMID
22867771
Full Text

Curtis, LH, Hammill, BG, Schulman, KA, and Cousins, SW. "In reply." Archives of Ophthalmology 130, no. 6 (June 1, 2012): 807-null.

Full Text

Pages